Although IL-1β mRNA levels tend be upregulated in depression patients (p = 0.0606, Figure 2), no significant differences were found between the mRNA levels of IL-1β nor CCL2 in PBMCs of depression patients and healthy controls. This evidence concerns the gene CCL2 and depressive symptom measurement.